Temporal Changes of Lactate in CLASSIC Patients
Primary Purpose
Septic Shock
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Resuscitation fluid
Sponsored by
About this trial
This is an interventional basic science trial for Septic Shock
Eligibility Criteria
Inclusion Criteria: Participation in CLASSIC trial in any of the participating centres Exclusion Criteria: Lack of sufficient data for analysis
Sites / Locations
- Karolinska University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Conservative
Traditional (liberal)
Arm Description
Resuscitation fluids were only given under certain pre-defined criteria
Patients were treated with standard of care for each site with regards to recuscitation fluids.
Outcomes
Primary Outcome Measures
Time to resolution of hyperlactemia
Blood lactate < 2.0 mmol/L
Secondary Outcome Measures
Temporal changes in lactate concentrations over time
Difference in blood lactate at during the first 72h from enrollment
Full Information
NCT ID
NCT05629780
First Posted
November 14, 2022
Last Updated
September 11, 2023
Sponsor
Karolinska University Hospital
Collaborators
Collabortation for Research in Intensive Care (CRIC), European Society of Intensive Care Medicine, Region Stockholm, The Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI)
1. Study Identification
Unique Protocol Identification Number
NCT05629780
Brief Title
Temporal Changes of Lactate in CLASSIC Patients
Official Title
Temporal Changes in Plasma Lactate Concentration in Critically Ill Patients With Septic Shock Treated With Restrictive Compared to Standard Fluid Therapy
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
September 29, 2022 (Actual)
Primary Completion Date
December 28, 2022 (Actual)
Study Completion Date
June 14, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska University Hospital
Collaborators
Collabortation for Research in Intensive Care (CRIC), European Society of Intensive Care Medicine, Region Stockholm, The Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aim to examine if randomization to different treatment strategies had any effect on the time to normalization of lactate in intensive care patients treated for septic shock.
Detailed Description
This is a retrospective analysis of a subset of patients included in the Conservative versus Liberal Approach to fluid therapy of Septic Shock in Intensive Care (CLASSIC) trial.
In the CLASSIC trial patients with septic shock were randomized to either traditional (liberal) strategy for fluid treatment or a more conservative regimen. The study was an international multicenter clinical trial (clinicaltrials.gov NCT03668236), and results were published in New England Journal of Medicine in June 2022 (DOI: 10.1056/NEJMoa2202707).
In this substudy the investigator extract all lactate values for the study period from all patients included from Karolinska University Hospital, Sundsvall and Södersjukhuset (Sweden), participating centers on Zealand (Denmark), and Plzen University Hospital (Czech Republic). Baseline data, treatment allocation and amount of fluids administered are collected as well as outcome from CLASSIC study.
Primary outcome is time to lactate normalization (< 2mmol/L). Secondary outcome is lactate concentration over the first 72 hours (as peak lactate for the time intervals 0-3, 3-6, 6-12, 12-24 and then each 12h-period between 24 and 72 hours).
The subgroup with blood lactate > 4mmol/L will be analyzed separately for the same end points.
Time to resolution of hyperlactatemia will be modelled with a competing risks regression. Death and discharge will be competing outcomes, and administrative censoring imposed 72 hours after randomisation.
Factors associated with time to lactate normalization will be examined through regression analysis. Factors that show a relationship on univariate analysis will be included in a multivariate analysis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a retrospective analysis of patients recruited to an interventional multicenter trial.
Masking
Investigator
Masking Description
All patients are included and analyzed for outcomes in the CLASSIC trial. The allocation and amount of fluids received for the included subjects are blinded for the investigator at the time point of analysis.
Allocation
Randomized
Enrollment
777 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Conservative
Arm Type
Experimental
Arm Description
Resuscitation fluids were only given under certain pre-defined criteria
Arm Title
Traditional (liberal)
Arm Type
No Intervention
Arm Description
Patients were treated with standard of care for each site with regards to recuscitation fluids.
Intervention Type
Drug
Intervention Name(s)
Resuscitation fluid
Intervention Description
Cristalloid fluids given as a resuscitational intervention
Primary Outcome Measure Information:
Title
Time to resolution of hyperlactemia
Description
Blood lactate < 2.0 mmol/L
Time Frame
72 hours
Secondary Outcome Measure Information:
Title
Temporal changes in lactate concentrations over time
Description
Difference in blood lactate at during the first 72h from enrollment
Time Frame
72 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participation in CLASSIC trial in any of the participating centres
Exclusion Criteria:
Lack of sufficient data for analysis
Facility Information:
Facility Name
Karolinska University Hospital
City
Stockholm
ZIP/Postal Code
14186
Country
Sweden
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
35709019
Citation
Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, Jakob SM, Cecconi M, Nalos M, Ostermann M, Malbrain M, Pettila V, Moller MH, Kjaer MN, Lange T, Overgaard-Steensen C, Brand BA, Winther-Olesen M, White JO, Quist L, Westergaard B, Jonsson AB, Hjortso CJS, Meier N, Jensen TS, Engstrom J, Nebrich L, Andersen-Ranberg NC, Jensen JV, Joseph NA, Poulsen LM, Herlov LS, Solling CG, Pedersen SK, Knudsen KK, Straarup TS, Vang ML, Bundgaard H, Rasmussen BS, Aagaard SR, Hildebrandt T, Russell L, Bestle MH, Schonemann-Lund M, Brochner AC, Elvander CF, Hoffmann SKL, Rasmussen ML, Martin YK, Friberg FF, Seter H, Aslam TN, Adnoy S, Seidel P, Strand K, Johnstad B, Joelsson-Alm E, Christensen J, Ahlstedt C, Pfortmueller CA, Siegemund M, Greco M, Radej J, Kriz M, Gould DW, Rowan KM, Mouncey PR, Perner A; CLASSIC Trial Group. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl J Med. 2022 Jun 30;386(26):2459-2470. doi: 10.1056/NEJMoa2202707. Epub 2022 Jun 17.
Results Reference
result
Learn more about this trial
Temporal Changes of Lactate in CLASSIC Patients
We'll reach out to this number within 24 hrs